These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39048319)

  • 1. Diverging Relationships among Amyloid, Tau, and Brain Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.
    Na HK; Shin JH; Kim SW; Seo S; Kim WR; Kang JM; Lee SY; Cho J; Byun J; Okamura N; Seong JK; Noh Y
    Yonsei Med J; 2024 Aug; 65(8):434-447. PubMed ID: 39048319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the APOEɛ4 Allele on the Relationship Between Tau and Amyloid-β in Early- and Late-Onset Alzheimer's Disease.
    Kang JM; Shin JH; Kim WR; Seo S; Seo H; Lee SY; Park KH; Na DL; Okamura N; Seong JK; Noh Y
    J Alzheimers Dis; 2023; 94(3):1233-1246. PubMed ID: 37393505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Subcortical Structural Shapes With Tau, Amyloid, and Cortical Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.
    Lee EC; Kang JM; Seo S; Seo HE; Lee SY; Park KH; Na DL; Noh Y; Seong JK
    Front Aging Neurosci; 2020; 12():563559. PubMed ID: 33192457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau positron emission tomography using [
    Kang JM; Lee SY; Seo S; Jeong HJ; Woo SH; Lee H; Lee YB; Yeon BK; Shin DH; Park KH; Kang H; Okamura N; Furumoto S; Yanai K; Villemagne VL; Seong JK; Na DL; Ido T; Cho J; Lee KM; Noh Y
    Neurobiol Aging; 2017 Nov; 59():210-219. PubMed ID: 28890300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R; Schonhaut DR; Schöll M; Lockhart SN; Ayakta N; Baker SL; O'Neil JP; Janabi M; Lazaris A; Cantwell A; Vogel J; Santos M; Miller ZA; Bettcher BM; Vossel KA; Kramer JH; Gorno-Tempini ML; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid deposition in early onset versus late onset Alzheimer's disease.
    Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
    J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Bejanin A; Schonhaut DR; La Joie R; Kramer JH; Baker SL; Sosa N; Ayakta N; Cantwell A; Janabi M; Lauriola M; O'Neil JP; Gorno-Tempini ML; Miller ZA; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2017 Dec; 140(12):3286-3300. PubMed ID: 29053874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.
    Cho H; Choi JY; Lee SH; Lee JH; Choi YC; Ryu YH; Lee MS; Lyoo CH
    Neurobiol Aging; 2017 May; 53():103-111. PubMed ID: 28254589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.
    Visser D; Verfaillie SCJ; Wolters EE; Coomans EM; Timmers T; Tuncel H; Boellaard R; Golla SSV; Windhorst AD; Scheltens P; van der Flier WM; van Berckel BNM; Ossenkoppele R
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1951-1963. PubMed ID: 34997294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
    Nihashi T; Sakurai K; Kato T; Iwata K; Kimura Y; Ikenuma H; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Suzuki K; Bundo M; Sakurai T; Okamura N; Yanai K; Ito K; Nakamura A;
    J Alzheimers Dis; 2022; 85(1):223-234. PubMed ID: 34776443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity.
    Park JE; Yun J; Kim SJ; Shim WH; Oh JS; Oh M; Roh JH; Seo SW; Oh SJ; Kim JS
    PLoS One; 2019; 14(12):e0226265. PubMed ID: 31834916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Cho H; Mundada NS; Apostolova LG; Carrillo MC; Shankar R; Amuiri AN; Zeltzer E; Windon CC; Soleimani-Meigooni DN; Tanner JA; Heath CL; Lesman-Segev OH; Aisen P; Eloyan A; Lee HS; Hammers DB; Kirby K; Dage JL; Fagan A; Foroud T; Grinberg LT; Jack CR; Kramer J; Kukull WA; Murray ME; Nudelman K; Toga A; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez M; Musiek E; Onyike CU; Riddle M; Rogalski EJ; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Koeppe R; Iaccarino L; Dickerson BC; La Joie R; Rabinovici GD;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S98-S114. PubMed ID: 37690109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer's disease.
    Contador J; Pérez-Millán A; Tort-Merino A; Balasa M; Falgàs N; Olives J; Castellví M; Borrego-Écija S; Bosch B; Fernández-Villullas G; Ramos-Campoy O; Antonell A; Bargalló N; Sanchez-Valle R; Sala-Llonch R; Lladó A;
    Neuroimage Clin; 2021; 32():102804. PubMed ID: 34474317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Comparison of Tau Radioligands
    Betthauser TJ; Lao PJ; Murali D; Barnhart TE; Furumoto S; Okamura N; Stone CK; Johnson SC; Christian BT
    J Nucl Med; 2017 Jun; 58(6):996-1002. PubMed ID: 27856627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
    Joubert S; Gour N; Guedj E; Didic M; Guériot C; Koric L; Ranjeva JP; Felician O; Guye M; Ceccaldi M
    Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
    Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO
    J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.
    Villemagne VL; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Hodges J; Harada R; Yates P; Piguet O; Pejoska S; Doré V; Yanai K; Masters CL; Kudo Y; Rowe CC; Okamura N
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):816-26. PubMed ID: 24514874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease.
    Aziz AL; Giusiano B; Joubert S; Duprat L; Didic M; Gueriot C; Koric L; Boucraut J; Felician O; Ranjeva JP; Guedj E; Ceccaldi M
    Neurobiol Aging; 2017 Jun; 54():22-30. PubMed ID: 28314160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.